The current array of healthcare reforms hasn’t produced a single reimbursement model that can replace our reliance on a fee-for-service (FFS) foundation, nor has it accounted for the...
In earlier posts on the new frontier of Molecular Diagnostic testing, I’ve discussed the need for identifying and classifying tests as well as the opportunity and challenges this new technology...
“Changing the future of claims processing.” That’s how ACO News reported McKesson Episode Management’s™ recent release of 22 new episodes based on the PROMETHEUS...
A dramatic rise in spending on molecular diagnostic (MDx) tests, coupled with an inability to identify specific MDx tests submitted on claims, led Palmetto GBA, to initiate the Palmetto MolDX...
Molecular Diagnostics (MDx), the next wave of innovation in healthcare technology, is arriving. Exciting, challenging, transformational, hopeful, complex, alarming, terrifying and expensive are all...
RAND: HHS Should Create National Value-Based Purchasing Strategy rtag.co/XIzX
Smart Drumming Prosthetic Plays Better Than Real Arm (VIDEO) rtag.co/XIzo
Using technology to engage patients in healthcare decisions | Government Health IT rtag.co/XIzM
Stem cell therapy improves Parkinson's symptoms in monkeys - FierceBiotech Research rtag.co/XIzZ
Curing Cancer in a Zillion Easy Steps | Voice of San Diego rtag.co/XIzn #bigdata #hit
Cost and Quality Improvement
Personalized Medicine/Molecular Diagnostics (MDx)
Point-of-Care Decision Management
Provider Network Management
Waste, Abuse and Fraud Prevention
Fredric Leary, MD
Jacqueline Mitus, MD
Douglas Moeller, MD
David Nace, MD
Emad Rizk, MD
Better Thinking for Better Health